,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1455240,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,56241,SUSD2,https://ctdbase.org/detail.go?type=gene&acc=56241,,,56241,SUSD2,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SUSD2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1,1455241,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6839,SUV39H1,https://ctdbase.org/detail.go?type=gene&acc=6839,,,6839,SUV39H1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SUV39H1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
2,1455242,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,794707,SYT11B,https://ctdbase.org/detail.go?type=gene&acc=794707,,,794707,syt11b,8049,Gadus morhua (Atlantic cod),Perfluoro-n-nonanoic acid results in increased expression of SYT11B mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
3,1455933,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,7980,TFPI2,https://ctdbase.org/detail.go?type=gene&acc=7980,,,7980,TFPI2,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of TFPI2 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
4,1455667,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7873,MANF,https://ctdbase.org/detail.go?type=gene&acc=7873,,,7873,MANF,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of MANF mRNA",,,PMID:35598417,https://www.ncbi.nlm.nih.gov/pubmed/35598417,35598417,,
5,1455668,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,7873,MANF,https://ctdbase.org/detail.go?type=gene&acc=7873,,,7873,MANF,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MANF protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
6,1455669,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4128,MAOA,https://ctdbase.org/detail.go?type=gene&acc=4128,,,4128,MAOA,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MAOA mRNA",,,PMID:25912373,https://www.ncbi.nlm.nih.gov/pubmed/25912373,25912373,,
7,1494290,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6205,RPS11,https://ctdbase.org/detail.go?type=gene&acc=6205,,,6205,RPS11,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPS11 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
8,1494291,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6206,RPS12,https://ctdbase.org/detail.go?type=gene&acc=6206,,,6206,RPS12,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPS12 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
9,1495095,91773,Drug Gene Interaction database (DGIdb),Tebufenozide,,TEBUFENOZIDE,https://www.dgidb.org/drugs/chembl:CHEMBL226968,,AR,https://www.dgidb.org/genes/hgnc:644,,,367,AR,9606,Homo sapiens (human),,,,,,,,
10,1495096,91779,Toxin and Toxin Target Database (T3DB),Rimsulfuron,T3D4535,Rimsulfuron,http://www.t3db.ca/toxins/T3D4535,BE0003543,Cytochrome P450 1A1,http://www.t3db.ca/biodb/bio_entities/BE0003543,P04798,Cytochrome P450 1A1,1543,CYP1A1,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
11,1495097,91779,Toxin and Toxin Target Database (T3DB),Rimsulfuron,T3D4535,Rimsulfuron,http://www.t3db.ca/toxins/T3D4535,BE0001047,C-C motif chemokine 2,http://www.t3db.ca/biodb/bio_entities/BE0001047,P13500,C-C motif chemokine 2,6347,CCL2,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
12,1495098,91779,Toxin and Toxin Target Database (T3DB),Rimsulfuron,T3D4535,Rimsulfuron,http://www.t3db.ca/toxins/T3D4535,BE0000934,C-X-C motif chemokine 10,http://www.t3db.ca/biodb/bio_entities/BE0000934,P02778,C-X-C motif chemokine 10,3627,CXCL10,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
13,1455406,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594,MAPK1,150808,Bathymodiolus azoricus,Peptidoglycan results in increased phosphorylation of MAPK1 protein,,,PMID:19041413,https://www.ncbi.nlm.nih.gov/pubmed/19041413,19041413,,
14,1455407,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594,MAPK1,9606,Homo sapiens (human),Peptidoglycan results in increased phosphorylation of MAPK1 protein,,,PMID:21647617,https://www.ncbi.nlm.nih.gov/pubmed/21647617,21647617,,
15,1455408,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594,MAPK1,10090,Mus musculus (house mouse),Peptidoglycan results in increased phosphorylation of MAPK1 protein|2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [peptidoglycan results in increased phosphorylation of MAPK1 protein]|zinc protoporphyrin promotes the reaction [peptidoglycan results in increased phosphorylation of MAPK1 protein],,,PMID:19376148,https://www.ncbi.nlm.nih.gov/pubmed/19376148,19376148,,
16,1455409,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,150808,Bathymodiolus azoricus,Peptidoglycan results in increased phosphorylation of MAPK3 protein,,,PMID:19041413,https://www.ncbi.nlm.nih.gov/pubmed/19041413,19041413,,
17,1455410,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,9606,Homo sapiens (human),Peptidoglycan results in increased phosphorylation of MAPK3 protein,,,PMID:21647617,https://www.ncbi.nlm.nih.gov/pubmed/21647617,21647617,,
18,1494959,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,30390,CYP19A1A,https://ctdbase.org/detail.go?type=gene&acc=30390,,,30390,cyp19a1a,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of CYP19A1A mRNA",,,PMID:25565004,https://www.ncbi.nlm.nih.gov/pubmed/25565004,25565004,,
19,1494960,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,60640,CYP19A1B,https://ctdbase.org/detail.go?type=gene&acc=60640,,,60640,cyp19a1b,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether analog results in decreased expression of CYP19A1B mRNA",,,PMID:25565004,https://www.ncbi.nlm.nih.gov/pubmed/25565004,25565004,,
20,1455793,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514,SLC2A2,10090,Mus musculus (house mouse),Glucose results in increased expression of and affects the localization of SLC2A2 protein,,,PMID:12937289,https://www.ncbi.nlm.nih.gov/pubmed/12937289,12937289,,
21,1455794,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514,SLC2A2,10090,Mus musculus (house mouse),Glucose results in increased expression of SLC2A2 mRNA,,,PMID:17786952,https://www.ncbi.nlm.nih.gov/pubmed/17786952,17786952,,
22,1455795,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514,SLC2A2,10116,Rattus norvegicus (Norway rat),Dactinomycin inhibits the reaction [glucose results in increased expression of SLC2A2 mrna],,,PMID:12787936,https://www.ncbi.nlm.nih.gov/pubmed/12787936,12787936,,
23,1455796,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514,SLC2A2,10116,Rattus norvegicus (Norway rat),Glucose results in increased expression of SLC2A2 mRNA,,,PMID:12787936|PMID:1727734,https://www.ncbi.nlm.nih.gov/pubmed/12787936|https://www.ncbi.nlm.nih.gov/pubmed/1727734,12787936|1727734,,
24,1455797,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514,SLC2A2,10116,Rattus norvegicus (Norway rat),Phloretin inhibits the reaction [SLC2A2 protein results in increased uptake of glucose]|ml 7 inhibits the reaction [SLC2A2 protein results in increased uptake of glucose],,,PMID:17272349,https://www.ncbi.nlm.nih.gov/pubmed/17272349,17272349,,
25,1455798,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514,SLC2A2,9606,Homo sapiens (human),Glucose inhibits the reaction [SLC2A2 protein results in increased uptake of dehydroascorbic acid],,,PMID:23396969,https://www.ncbi.nlm.nih.gov/pubmed/23396969,23396969,,
26,1455799,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6515,SLC2A3,https://ctdbase.org/detail.go?type=gene&acc=6515,,,6515,SLC2A3,9606,Homo sapiens (human),Glucose inhibits the reaction [SLC2A3 protein results in increased transport of galactose]|glucose inhibits the reaction [SLC2A3 protein results in increased transport of deoxyglucose],,,PMID:8457197,https://www.ncbi.nlm.nih.gov/pubmed/8457197,8457197,,
27,1455800,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6515,SLC2A3,https://ctdbase.org/detail.go?type=gene&acc=6515,,,6515,SLC2A3,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of SLC2A3 protein|kynurenic acid inhibits the reaction [[INS protein co-treated with glucose] results in decreased expression of SLC2A3 protein],,,PMID:28951307,https://www.ncbi.nlm.nih.gov/pubmed/28951307,28951307,,
28,1455801,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6515,SLC2A3,https://ctdbase.org/detail.go?type=gene&acc=6515,,,6515,SLC2A3,10116,Rattus norvegicus (Norway rat),[oxygen co-treated with glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[oxygen co-treated with glucose deficiency co-treated with 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxyglucopyranoside] results in increased expression of SLC2A3 protein],,,PMID:24726522,https://www.ncbi.nlm.nih.gov/pubmed/24726522,24726522,,
29,1454922,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627,BDNF,9606,Homo sapiens (human),Deguelin results in increased expression of BDNF mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
30,1454923,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627,BDNF,10090,Mus musculus (house mouse),Deguelin inhibits the reaction [BDNF protein results in increased expression of PPP1R1B protein],,,PMID:17209049,https://www.ncbi.nlm.nih.gov/pubmed/17209049,17209049,,
31,1454924,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,637,BID,https://ctdbase.org/detail.go?type=gene&acc=637,,,637,BID,9606,Homo sapiens (human),Deguelin results in decreased expression of BID mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
32,1454925,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332,BIRC5,9606,Homo sapiens (human),Deguelin inhibits the reaction [docetaxel results in increased expression of BIRC5 protein]|deguelin inhibits the reaction [doxorubicin results in increased expression of BIRC5 protein],,,PMID:17035597,https://www.ncbi.nlm.nih.gov/pubmed/17035597,17035597,,
33,1454926,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332,BIRC5,9606,Homo sapiens (human),Deguelin results in decreased expression of BIRC5 protein,,,PMID:17035597|PMID:18593368|PMID:21472727,https://www.ncbi.nlm.nih.gov/pubmed/17035597|https://www.ncbi.nlm.nih.gov/pubmed/18593368|https://www.ncbi.nlm.nih.gov/pubmed/21472727,17035597|18593368|21472727,,
34,1454927,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,332,BIRC5,https://ctdbase.org/detail.go?type=gene&acc=332,,,332,BIRC5,9606,Homo sapiens (human),Deguelin results in increased expression of BIRC5 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
35,1493569,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,10869,USP19,https://ctdbase.org/detail.go?type=gene&acc=10869,,,10869,USP19,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of USP19 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
36,1493570,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,10868,USP20,https://ctdbase.org/detail.go?type=gene&acc=10868,,,10868,USP20,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of USP20 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
37,1493571,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,9101,USP8,https://ctdbase.org/detail.go?type=gene&acc=9101,,,9101,USP8,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of USP8 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
38,1493572,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,51118,UTP11,https://ctdbase.org/detail.go?type=gene&acc=51118,,,51118,UTP11,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of UTP11 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
39,1493573,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422,VEGFA,9606,Homo sapiens (human),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of VEGFA mRNA",,,PMID:35548680,https://www.ncbi.nlm.nih.gov/pubmed/35548680,35548680,,
40,1493392,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606,IL18,9606,Homo sapiens (human),Fraxinellone inhibits the reaction [dextran sulfate results in increased expression of IL18 protein]|fraxinellone inhibits the reaction [lipopolysaccharides results in increased expression of IL18 protein],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
41,1493393,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553,IL1B,9606,Homo sapiens (human),Fraxinellone inhibits the reaction [dextran sulfate results in increased expression of IL1B protein]|fraxinellone inhibits the reaction [lipopolysaccharides results in increased expression of IL1B protein],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
42,1493394,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10090,Mus musculus (house mouse),Fraxinellone inhibits the reaction [dextran sulfate results in increased expression of IL6 protein],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
43,1493395,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353,MPO,10090,Mus musculus (house mouse),Fraxinellone inhibits the reaction [dextran sulfate results in increased activity of MPO protein],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
44,1493396,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792,NFKBIA,9606,Homo sapiens (human),Fraxinellone inhibits the reaction [lipopolysaccharides results in increased phosphorylation of NFKBIA protein],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
45,1493397,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843,NOS2,9606,Homo sapiens (human),Fraxinellone inhibits the reaction [dextran sulfate results in increased expression of NOS2 mrna]|fraxinellone inhibits the reaction [lipopolysaccharides results in increased activity of NOS2 protein],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
46,1493398,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,10090,Mus musculus (house mouse),Fraxinellone inhibits the reaction [dextran sulfate results in increased expression of PTGS2 mrna],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
47,1493399,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,9606,Homo sapiens (human),Fraxinellone inhibits the reaction [lipopolysaccharides results in increased phosphorylation of and affects the localization of RELA protein],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
48,1493400,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10090,Mus musculus (house mouse),Fraxinellone inhibits the reaction [dextran sulfate results in increased expression of TNF protein],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
49,1493401,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412,VCAM1,10090,Mus musculus (house mouse),Fraxinellone inhibits the reaction [dextran sulfate results in increased expression of VCAM1 mrna],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
50,1494282,125483,Comparative Toxicogenomics Database (CTD),4-Nitrososulfamethoxazole,C072956,4-nitrososulfamethoxazole,https://ctdbase.org/detail.go?type=chem&acc=C072956,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728,NQO1,9606,Homo sapiens (human),4-nitrososulfamethoxazole results in increased expression of NQO1 mRNA,,,PMID:28444390,https://www.ncbi.nlm.nih.gov/pubmed/28444390,28444390,,
51,1494283,125483,Comparative Toxicogenomics Database (CTD),4-Nitrososulfamethoxazole,C072956,4-nitrososulfamethoxazole,https://ctdbase.org/detail.go?type=chem&acc=C072956,140809,SRXN1,https://ctdbase.org/detail.go?type=gene&acc=140809,,,140809,SRXN1,9606,Homo sapiens (human),4-nitrososulfamethoxazole results in increased expression of SRXN1 mRNA,,,PMID:28444390,https://www.ncbi.nlm.nih.gov/pubmed/28444390,28444390,,
52,1494284,125483,Comparative Toxicogenomics Database (CTD),4-Nitrososulfamethoxazole,C072956,4-nitrososulfamethoxazole,https://ctdbase.org/detail.go?type=chem&acc=C072956,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,9606,Homo sapiens (human),4-nitrososulfamethoxazole results in increased secretion of TNF protein,,,PMID:28444390,https://www.ncbi.nlm.nih.gov/pubmed/28444390,28444390,,
53,1494285,125483,Comparative Toxicogenomics Database (CTD),4-Nitrososulfamethoxazole,C072956,4-nitrososulfamethoxazole,https://ctdbase.org/detail.go?type=chem&acc=C072956,7296,TXNRD1,https://ctdbase.org/detail.go?type=gene&acc=7296,,,7296,TXNRD1,9606,Homo sapiens (human),4-nitrososulfamethoxazole results in increased expression of TXNRD1 mRNA,,,PMID:28444390,https://www.ncbi.nlm.nih.gov/pubmed/28444390,28444390,,
54,1494286,125564,IUPHAR/BPS Guide to PHARMACOLOGY,Blonanserin,7670,blonanserin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7670,6,5-HT2A receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=6,P28223,5-hydroxytryptamine receptor 2A,3356,HTR2A,9606,Homo sapiens (human),Antagonist,pKi,9.09,PMID:15686911,https://www.ncbi.nlm.nih.gov/pubmed/15686911,15686911,,
55,1494287,126274,Comparative Toxicogenomics Database (CTD),Meisoindigo,C047330,N-methylisoindigotin,https://ctdbase.org/detail.go?type=chem&acc=C047330,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31,ACACA,9606,Homo sapiens (human),N-methylisoindigotin results in increased phosphorylation of ACACA protein,,,PMID:26887594,https://www.ncbi.nlm.nih.gov/pubmed/26887594,26887594,,
56,1494288,126274,Comparative Toxicogenomics Database (CTD),Meisoindigo,C047330,N-methylisoindigotin,https://ctdbase.org/detail.go?type=chem&acc=C047330,54806,AHI1,https://ctdbase.org/detail.go?type=gene&acc=54806,,,54806,AHI1,9606,Homo sapiens (human),N-methylisoindigotin results in increased expression of and affects the localization of AHI1 protein alternative form,,,PMID:19379585,https://www.ncbi.nlm.nih.gov/pubmed/19379585,19379585,,
57,1494289,126274,Comparative Toxicogenomics Database (CTD),Meisoindigo,C047330,N-methylisoindigotin,https://ctdbase.org/detail.go?type=chem&acc=C047330,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999,CDH1,9606,Homo sapiens (human),N-methylisoindigotin results in increased expression of CDH1 mRNA,,,PMID:26887594,https://www.ncbi.nlm.nih.gov/pubmed/26887594,26887594,,
58,1454928,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9793,CKAP5,https://ctdbase.org/detail.go?type=gene&acc=9793,,,9793,CKAP5,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of CKAP5 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
59,1456070,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1665,DHX15,https://ctdbase.org/detail.go?type=gene&acc=1665,,,1665,DHX15,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DHX15 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
60,1456071,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,170506,DHX36,https://ctdbase.org/detail.go?type=gene&acc=170506,,,170506,DHX36,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DHX36 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
61,1456072,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1659,DHX8,https://ctdbase.org/detail.go?type=gene&acc=1659,,,1659,DHX8,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DHX8 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
62,1456073,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1729,DIAPH1,https://ctdbase.org/detail.go?type=gene&acc=1729,,,1729,DIAPH1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of DIAPH1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
63,1456074,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,1730,DIAPH2,https://ctdbase.org/detail.go?type=gene&acc=1730,,,1730,DIAPH2,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of DIAPH2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
64,1456075,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23405,DICER1,https://ctdbase.org/detail.go?type=gene&acc=23405,,,23405,DICER1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of DICER1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
65,1494968,155011,Comparative Toxicogenomics Database (CTD),Aurantio-obtusin,C000595611,aurantio-obtusin,https://ctdbase.org/detail.go?type=chem&acc=C000595611,2182,ACSL4,https://ctdbase.org/detail.go?type=gene&acc=2182,,,2182,ACSL4,9606,Homo sapiens (human),Aurantio-obtusin results in increased expression of ACSL4 protein,,,PMID:35995123,https://www.ncbi.nlm.nih.gov/pubmed/35995123,35995123,,
66,1493218,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,83448,PUS7L,https://ctdbase.org/detail.go?type=gene&acc=83448,,,83448,PUS7L,9606,Homo sapiens (human),Abrine results in decreased expression of PUS7L mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
67,1493219,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5817,PVR,https://ctdbase.org/detail.go?type=gene&acc=5817,,,5817,PVR,9606,Homo sapiens (human),Abrine results in increased expression of PVR mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
68,1493220,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79037,PVRIG,https://ctdbase.org/detail.go?type=gene&acc=79037,,,79037,PVRIG,9606,Homo sapiens (human),Abrine results in increased expression of PVRIG mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
69,1493221,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,100286721,PVRL1,https://ctdbase.org/detail.go?type=gene&acc=100286721,,,100286721,,9606,Homo sapiens (human),Abrine results in decreased expression of PVRL1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
70,1493222,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,102854599,PVRL3,https://ctdbase.org/detail.go?type=gene&acc=102854599,,,102854599,,9606,Homo sapiens (human),Abrine results in decreased expression of PVRL3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
71,1493223,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,84939,PWWP3A,https://ctdbase.org/detail.go?type=gene&acc=84939,,,84939,PWWP3A,9606,Homo sapiens (human),Abrine results in decreased expression of PWWP3A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
72,1493224,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,221749,PXDC1,https://ctdbase.org/detail.go?type=gene&acc=221749,,,221749,PXDC1,9606,Homo sapiens (human),Abrine results in increased expression of PXDC1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
73,1493225,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,7837,PXDN,https://ctdbase.org/detail.go?type=gene&acc=7837,,,7837,PXDN,9606,Homo sapiens (human),Abrine results in decreased expression of PXDN mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
74,1493226,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,11264,PXMP4,https://ctdbase.org/detail.go?type=gene&acc=11264,,,11264,PXMP4,9606,Homo sapiens (human),Abrine results in decreased expression of PXMP4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
75,1493897,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5873,RAB27A,https://ctdbase.org/detail.go?type=gene&acc=5873,,,5873,RAB27A,9606,Homo sapiens (human),Abrine results in decreased expression of RAB27A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
76,1493898,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5874,RAB27B,https://ctdbase.org/detail.go?type=gene&acc=5874,,,5874,RAB27B,9606,Homo sapiens (human),Abrine results in decreased expression of RAB27B mrna|abrine results in increased expression of RAB27B protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
77,1493899,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,27314,RAB30,https://ctdbase.org/detail.go?type=gene&acc=27314,,,27314,RAB30,9606,Homo sapiens (human),Abrine results in increased expression of RAB30 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
78,1493900,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,11031,RAB31,https://ctdbase.org/detail.go?type=gene&acc=11031,,,11031,RAB31,9606,Homo sapiens (human),Abrine results in decreased expression of RAB31 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
79,1493901,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,10981,RAB32,https://ctdbase.org/detail.go?type=gene&acc=10981,,,10981,RAB32,9606,Homo sapiens (human),Abrine results in increased expression of RAB32 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
80,1493902,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,326624,RAB37,https://ctdbase.org/detail.go?type=gene&acc=326624,,,326624,RAB37,9606,Homo sapiens (human),Abrine results in decreased expression of RAB37 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
81,1493903,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23682,RAB38,https://ctdbase.org/detail.go?type=gene&acc=23682,,,23682,RAB38,9606,Homo sapiens (human),Abrine results in increased expression of RAB38 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
82,1493904,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,116442,RAB39B,https://ctdbase.org/detail.go?type=gene&acc=116442,,,116442,RAB39B,9606,Homo sapiens (human),Abrine results in increased expression of RAB39B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
83,1494106,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9367,RAB9A,https://ctdbase.org/detail.go?type=gene&acc=9367,,,9367,RAB9A,9606,Homo sapiens (human),Abrine results in increased expression of RAB9A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
84,1494107,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,27342,RABGEF1,https://ctdbase.org/detail.go?type=gene&acc=27342,,,27342,RABGEF1,9606,Homo sapiens (human),Abrine results in increased expression of RABGEF1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
85,1494108,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5876,RABGGTB,https://ctdbase.org/detail.go?type=gene&acc=5876,,,5876,RABGGTB,9606,Homo sapiens (human),Abrine results in increased expression of RABGGTB mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
86,1495238,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C501996,methylarsonite,https://ctdbase.org/detail.go?type=chem&acc=C501996,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630,INS,10090,Mus musculus (house mouse),Methylarsonite inhibits the reaction [INS protein results in increased activity of GYS2 protein]|methylarsonite inhibits the reaction [INS protein results in decreased activity of PYGL protein],,,PMID:28952001,https://www.ncbi.nlm.nih.gov/pubmed/28952001,28952001,,
87,1495239,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C501996,methylarsonite,https://ctdbase.org/detail.go?type=chem&acc=C501996,16333,INS1,https://ctdbase.org/detail.go?type=gene&acc=16333,,,16333,Ins1,10090,Mus musculus (house mouse),"Methylarsonite inhibits the reaction [3-pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester promotes the reaction [glucose results in increased secretion of INS1 protein]]|tolbutamide inhibits the reaction [methylarsonite inhibits the reaction [glucose results in increased secretion of INS1 protein]]|3-pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, methyl ester inhibits the reaction [methylarsonite inhibits the reaction [glucose results in increased secretion of INS1 protein]]|methylarsonite inhibits the reaction [potassium chloride results in increased secretion of INS1 protein]|methylarsonite inhibits the reaction [glucose results in increased secretion of INS1 protein]",,,PMID:31332465,https://www.ncbi.nlm.nih.gov/pubmed/31332465,31332465,,
88,1495240,161491,Comparative Toxicogenomics Database (CTD),Methylarsonous acid,C501996,methylarsonite,https://ctdbase.org/detail.go?type=chem&acc=C501996,5836,PYGL,https://ctdbase.org/detail.go?type=gene&acc=5836,,,5836,PYGL,10090,Mus musculus (house mouse),Methylarsonite inhibits the reaction [INS protein results in decreased activity of PYGL protein],,,PMID:28952001,https://www.ncbi.nlm.nih.gov/pubmed/28952001,28952001,,
89,1495241,161825,Comparative Toxicogenomics Database (CTD),5-Hydroxypyrazine-2-carboxylic acid,C054996,5-hydroxypyrazinoic acid,https://ctdbase.org/detail.go?type=chem&acc=C054996,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10116,Rattus norvegicus (Norway rat),5-hydroxypyrazinoic acid results in decreased expression of CAT protein,,,PMID:28425350,https://www.ncbi.nlm.nih.gov/pubmed/28425350,28425350,,
90,1455078,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,36040,TER94,https://ctdbase.org/detail.go?type=gene&acc=36040,,,36040,TER94,7227,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of TER94 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
91,1455079,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,33294,TFB4,https://ctdbase.org/detail.go?type=gene&acc=33294,,,33294,Tfb4,7227,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of TFB4 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
92,1493731,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834,CASP1,10090,Mus musculus (house mouse),Curcumin inhibits the reaction [aflatoxin B1 results in increased expression of CASP1 protein]|aflatoxin B1 results in increased expression of CASP1 protein|aflatoxin B1 results in increased expression of CASP1 mrna|curcumin inhibits the reaction [aflatoxin B1 results in increased expression of CASP1 mrna],,,PMID:35063475,https://www.ncbi.nlm.nih.gov/pubmed/35063475,35063475,,
93,1493732,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,843,CASP10,https://ctdbase.org/detail.go?type=gene&acc=843,,,843,CASP10,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CASP10 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
94,1493733,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100506742,CASP12,https://ctdbase.org/detail.go?type=gene&acc=100506742,,,100506742,CASP12,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CASP12 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
95,1493734,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23581,CASP14,https://ctdbase.org/detail.go?type=gene&acc=23581,,,23581,CASP14,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of CASP14 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
96,1493735,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,197350,CASP16P,https://ctdbase.org/detail.go?type=gene&acc=197350,,,197350,CASP16P,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CASP16P intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
97,1493736,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9031,Gallus gallus (chicken),Sodium selenite inhibits the reaction [aflatoxin B1 results in increased expression of CASP3 mrna]|aflatoxin B1 results in increased expression of CASP3 mRNA,,,PMID:25261862,https://www.ncbi.nlm.nih.gov/pubmed/25261862,25261862,,
98,1493737,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Aflatoxin B1 promotes the reaction [deoxynivalenol results in increased expression of CASP3 mrna]|[zearalenone co-treated with aflatoxin B1] promotes the reaction [deoxynivalenol results in increased expression of CASP3 mrna],,,PMID:30668976,https://www.ncbi.nlm.nih.gov/pubmed/30668976,30668976,,
99,1494619,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,254559,MIR9-3HG,https://ctdbase.org/detail.go?type=gene&acc=254559,,,254559,MIR9-3HG,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MIR9-3HG gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
100,1494620,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,407055,MIR99A,https://ctdbase.org/detail.go?type=gene&acc=407055,,,407055,MIR99A,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR99A mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
101,1494621,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,388815,MIR99AHG,https://ctdbase.org/detail.go?type=gene&acc=388815,,,388815,MIR99AHG,9606,Homo sapiens (human),Aflatoxin B1 affects the methylation of MIR99AHG intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
102,1494622,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,388815,MIR99AHG,https://ctdbase.org/detail.go?type=gene&acc=388815,,,388815,MIR99AHG,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of MIR99AHG mRNA,,,PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,22100608|27153756,,
103,1494623,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,388815,MIR99AHG,https://ctdbase.org/detail.go?type=gene&acc=388815,,,388815,MIR99AHG,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MIR99AHG gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
104,1494624,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,387253,MIRLET7F-2,https://ctdbase.org/detail.go?type=gene&acc=387253,,,387253,Mirlet7f-2,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIRLET7F-2 mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
105,1494625,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79003,MIS12,https://ctdbase.org/detail.go?type=gene&acc=79003,,,79003,MIS12,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of MIS12 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
106,1494626,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,54069,MIS18A,https://ctdbase.org/detail.go?type=gene&acc=54069,,,54069,MIS18A,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of MIS18A protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
107,1494627,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55320,MIS18BP1,https://ctdbase.org/detail.go?type=gene&acc=55320,,,55320,MIS18BP1,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of MIS18BP1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
108,1494628,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55320,MIS18BP1,https://ctdbase.org/detail.go?type=gene&acc=55320,,,55320,MIS18BP1,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of MIS18BP1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
109,1455233,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1522,CTSZ,https://ctdbase.org/detail.go?type=gene&acc=1522,,,1522,CTSZ,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of CTSZ mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
110,1455234,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1522,CTSZ,https://ctdbase.org/detail.go?type=gene&acc=1522,,,1522,CTSZ,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CTSZ mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
111,1455235,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2017,CTTN,https://ctdbase.org/detail.go?type=gene&acc=2017,,,2017,CTTN,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of CTTN mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
112,1455236,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,55917,CTTNBP2NL,https://ctdbase.org/detail.go?type=gene&acc=55917,,,55917,CTTNBP2NL,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CTTNBP2NL mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
113,1455237,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,41339,CU,https://ctdbase.org/detail.go?type=gene&acc=41339,,,41339,cu,7227,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of CU mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
114,1455238,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8453,CUL2,https://ctdbase.org/detail.go?type=gene&acc=8453,,,8453,CUL2,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CUL2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
115,1455239,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,8452,CUL3,https://ctdbase.org/detail.go?type=gene&acc=8452,,,8452,CUL3,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CUL3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
116,1455670,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,182018,CUTL-14,https://ctdbase.org/detail.go?type=gene&acc=182018,,,182018,cutl-14,6239,Caenorhabditis elegans,CUTL-14 protein results in decreased susceptibility to methylmercuric chloride,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
117,1455671,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174065,CUTL-16,https://ctdbase.org/detail.go?type=gene&acc=174065,,,174065,cutl-16,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUTL-16 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
118,1455672,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,179565,CUTL-18,https://ctdbase.org/detail.go?type=gene&acc=179565,,,179565,cutl-18,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUTL-18 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
119,1455673,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,174532,CUTL-2,https://ctdbase.org/detail.go?type=gene&acc=174532,,,174532,cutl-2,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUTL-2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
120,1455674,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189610,CUTL-23,https://ctdbase.org/detail.go?type=gene&acc=189610,,,189610,cutl-23,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUTL-23 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
121,1455675,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,190305,CUTL-25,https://ctdbase.org/detail.go?type=gene&acc=190305,,,190305,cutl-25,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUTL-25 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
122,1455676,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,183003,CUTL-27,https://ctdbase.org/detail.go?type=gene&acc=183003,,,183003,cutl-27,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUTL-27 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
123,1455677,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176895,CUTL-28,https://ctdbase.org/detail.go?type=gene&acc=176895,,,176895,cutl-28,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of CUTL-28 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
124,1455925,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6376,CX3CL1,https://ctdbase.org/detail.go?type=gene&acc=6376,,,6376,CX3CL1,10090,Mus musculus (house mouse),Methylmercuric chloride results in decreased expression of CX3CL1 mRNA,,,PMID:29261810,https://www.ncbi.nlm.nih.gov/pubmed/29261810,29261810,,
125,1455926,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1525,CXADR,https://ctdbase.org/detail.go?type=gene&acc=1525,,,1525,CXADR,7955,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of CXADR mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
126,1455927,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919,CXCL1,10090,Mus musculus (house mouse),Methylmercuric chloride results in increased expression of CXCL1 mRNA,,,PMID:24213012,https://www.ncbi.nlm.nih.gov/pubmed/24213012,24213012,,
127,1455928,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627,CXCL10,10090,Mus musculus (house mouse),Methylmercuric chloride results in increased expression of CXCL10 mRNA,,,PMID:24213012|PMID:30103553,https://www.ncbi.nlm.nih.gov/pubmed/24213012|https://www.ncbi.nlm.nih.gov/pubmed/30103553,24213012|30103553,,
128,1455929,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627,CXCL10,10090,Mus musculus (house mouse),MT3 protein affects the reaction [methylmercuric chloride results in increased expression of CXCL10 mrna]|[mt3 protein affects the susceptibility to methylmercuric chloride] which affects the expression of CXCL10 mRNA,,,PMID:30103553,https://www.ncbi.nlm.nih.gov/pubmed/30103553,30103553,,
129,1455930,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627,CXCL10,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of CXCL10 mRNA,,,PMID:31378766,https://www.ncbi.nlm.nih.gov/pubmed/31378766,31378766,,
130,1455931,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3627,CXCL10,https://ctdbase.org/detail.go?type=gene&acc=3627,,,3627,CXCL10,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in increased expression of CXCL10 protein,,,PMID:28526320,https://www.ncbi.nlm.nih.gov/pubmed/28526320,28526320,,
131,1455932,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,6387,CXCL12,https://ctdbase.org/detail.go?type=gene&acc=6387,,,6387,CXCL12,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride affects the expression of CXCL12 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
132,1455070,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499,CTNNB1,10116,Rattus norvegicus (Norway rat),Lithium chloride results in increased activity of CTNNB1 protein,,,PMID:20694829,https://www.ncbi.nlm.nih.gov/pubmed/20694829,20694829,,
133,1455071,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499,CTNNB1,7668,Strongylocentrotus purpuratus (purple sea urchin),Lithium chloride results in decreased expression of CTNNB1 mRNA,,,PMID:17506889,https://www.ncbi.nlm.nih.gov/pubmed/17506889,17506889,,
134,1455072,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,3576,CXCL8,https://ctdbase.org/detail.go?type=gene&acc=3576,,,3576,CXCL8,9606,Homo sapiens (human),Lithium chloride inhibits the reaction [ERBB2 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased secretion of CXCL8 protein]]|lithium chloride inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CXCL8 mrna]|lithium chloride inhibits the reaction [ERBB2 protein promotes the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CXCL8 mrna]]|lithium chloride inhibits the reaction [[sodium arsenite results in increased abundance of arsenic] which results in increased secretion of CXCL8 protein],,,PMID:33396024,https://www.ncbi.nlm.nih.gov/pubmed/33396024,33396024,,
135,1455073,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,174522,CYP-13A10,https://ctdbase.org/detail.go?type=gene&acc=174522,,,174522,cyp-13A10,6239,Caenorhabditis elegans,Lithium chloride results in decreased expression of CYP-13A10 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
136,1455074,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,184473,CYP-13A12,https://ctdbase.org/detail.go?type=gene&acc=184473,,,184473,cyp-13A12,6239,Caenorhabditis elegans,Lithium chloride results in decreased expression of CYP-13A12 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
137,1455075,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,188356,CYP-13A5,https://ctdbase.org/detail.go?type=gene&acc=188356,,,188356,cyp-13A5,6239,Caenorhabditis elegans,Lithium chloride results in decreased expression of CYP-13A5 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
138,1455076,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,188362,CYP-13A7,https://ctdbase.org/detail.go?type=gene&acc=188362,,,188362,cyp-13A7,6239,Caenorhabditis elegans,Lithium chloride results in decreased expression of CYP-13A7 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
139,1455077,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,188358,CYP-13A8,https://ctdbase.org/detail.go?type=gene&acc=188358,,,188358,cyp-13A8,6239,Caenorhabditis elegans,Lithium chloride results in decreased expression of CYP-13A8 mRNA,,,PMID:25644961,https://www.ncbi.nlm.nih.gov/pubmed/25644961,25644961,,
140,1455401,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,796,CALCA,https://ctdbase.org/detail.go?type=gene&acc=796,,,796,CALCA,10116,Rattus norvegicus (Norway rat),CALCA protein results in increased abundance of norepinephrine,,,PMID:8058111,https://www.ncbi.nlm.nih.gov/pubmed/8058111,8058111,,
141,1455402,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,50632,CALY,https://ctdbase.org/detail.go?type=gene&acc=50632,,,50632,CALY,9606,Homo sapiens (human),CALY protein results in increased secretion of norepinephrine,,,PMID:30753204,https://www.ncbi.nlm.nih.gov/pubmed/30753204,30753204,,
142,1455403,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,100506742,CASP12,https://ctdbase.org/detail.go?type=gene&acc=100506742,,,100506742,CASP12,10116,Rattus norvegicus (Norway rat),CAT protein inhibits the reaction [norepinephrine results in increased cleavage of CASP12 protein alternative form]|norepinephrine results in increased cleavage of CASP12 protein alternative form|ngf protein inhibits the reaction [norepinephrine results in increased cleavage of CASP12 protein alternative form],,,PMID:16338971,https://www.ncbi.nlm.nih.gov/pubmed/16338971,16338971,,
143,1455404,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835,CASP2,10116,Rattus norvegicus (Norway rat),Acetylcysteine inhibits the reaction [norepinephrine results in increased activity of CASP2 protein],,,PMID:15158148|PMID:17041759,https://www.ncbi.nlm.nih.gov/pubmed/15158148|https://www.ncbi.nlm.nih.gov/pubmed/17041759,15158148|17041759,,
144,1455405,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,835,CASP2,https://ctdbase.org/detail.go?type=gene&acc=835,,,835,CASP2,10116,Rattus norvegicus (Norway rat),Ascorbic acid inhibits the reaction [norepinephrine results in increased activity of CASP2 protein],,,PMID:15158148,https://www.ncbi.nlm.nih.gov/pubmed/15158148,15158148,,
145,1455538,441401,ChEMBL,Linezolid,CHEMBL126,LINEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL126/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7N9,50S ribosomal protein L33,945190,rpmA,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:15992144,https://www.ncbi.nlm.nih.gov/pubmed/15992144,15992144,,
146,1455539,441401,ChEMBL,Linezolid,CHEMBL126,LINEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL126/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P02358,30S ribosomal protein S6,948723,rpsF,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:15992144,https://www.ncbi.nlm.nih.gov/pubmed/15992144,15992144,,
147,1494464,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,7184,HSP90B1,https://ctdbase.org/detail.go?type=gene&acc=7184,,,7184,HSP90B1,10116,Rattus norvegicus (Norway rat),Propiverine binds to HSP90B1 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
148,1494465,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,3308,HSPA4,https://ctdbase.org/detail.go?type=gene&acc=3308,,,3308,HSPA4,10116,Rattus norvegicus (Norway rat),Propiverine binds to HSPA4 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
149,1494466,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,3312,HSPA8,https://ctdbase.org/detail.go?type=gene&acc=3312,,,3312,HSPA8,10116,Rattus norvegicus (Norway rat),Propiverine affects the localization of HSPA8 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
150,1494467,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,3329,HSPD1,https://ctdbase.org/detail.go?type=gene&acc=3329,,,3329,HSPD1,10116,Rattus norvegicus (Norway rat),Propiverine binds to HSPD1 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
151,1494468,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,10525,HYOU1,https://ctdbase.org/detail.go?type=gene&acc=10525,,,10525,HYOU1,10116,Rattus norvegicus (Norway rat),Propiverine binds to HYOU1 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
152,1494469,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,3419,IDH3A,https://ctdbase.org/detail.go?type=gene&acc=3419,,,3419,IDH3A,10116,Rattus norvegicus (Norway rat),Propiverine binds to IDH3A protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
153,1494470,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,3611,ILK,https://ctdbase.org/detail.go?type=gene&acc=3611,,,3611,ILK,10116,Rattus norvegicus (Norway rat),Propiverine binds to ILK protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
154,1494471,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,3712,IVD,https://ctdbase.org/detail.go?type=gene&acc=3712,,,3712,IVD,10116,Rattus norvegicus (Norway rat),Propiverine binds to IVD protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
155,1493391,442458,Comparative Toxicogenomics Database (CTD),Sanggenon C,C477157,sanggenone C,https://ctdbase.org/detail.go?type=chem&acc=C477157,5770,PTPN1,https://ctdbase.org/detail.go?type=gene&acc=5770,,,5770,PTPN1,9606,Homo sapiens (human),Sanggenone C results in decreased activity of PTPN1 protein,,,PMID:16356713,https://www.ncbi.nlm.nih.gov/pubmed/16356713,16356713,,
156,1494472,442972,Comparative Toxicogenomics Database (CTD),Cyclopamine,C000541,cyclopamine,https://ctdbase.org/detail.go?type=chem&acc=C000541,2294,FOXF1,https://ctdbase.org/detail.go?type=gene&acc=2294,,,2294,FOXF1,7955,Danio rerio (zebrafish),Cyclopamine results in decreased expression of FOXF1 mRNA,,,PMID:22265815,https://www.ncbi.nlm.nih.gov/pubmed/22265815,22265815,,
157,1494473,442972,Comparative Toxicogenomics Database (CTD),Cyclopamine,C000541,cyclopamine,https://ctdbase.org/detail.go?type=chem&acc=C000541,407681,FOXF2A,https://ctdbase.org/detail.go?type=gene&acc=407681,,,407681,foxf2a,7955,Danio rerio (zebrafish),Cyclopamine results in decreased expression of FOXF2A mRNA,,,PMID:22265815,https://www.ncbi.nlm.nih.gov/pubmed/22265815,22265815,,
158,1455530,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23082,PPRC1,https://ctdbase.org/detail.go?type=gene&acc=23082,,,23082,PPRC1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PPRC1 mRNA,,,PMID:20883709,https://www.ncbi.nlm.nih.gov/pubmed/20883709,20883709,,
159,1455531,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5538,PPT1,https://ctdbase.org/detail.go?type=gene&acc=5538,,,5538,PPT1,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PPT1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
160,1455532,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5538,PPT1,https://ctdbase.org/detail.go?type=gene&acc=5538,,,5538,PPT1,9606,Homo sapiens (human),Sodium arsenite affects the expression of PPT1 mRNA,,,PMID:29319823,https://www.ncbi.nlm.nih.gov/pubmed/29319823,29319823,,
161,1455533,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23398,PPWD1,https://ctdbase.org/detail.go?type=gene&acc=23398,,,23398,PPWD1,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PPWD1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
162,1455534,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23398,PPWD1,https://ctdbase.org/detail.go?type=gene&acc=23398,,,23398,PPWD1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PPWD1 mRNA,,,PMID:22714537,https://www.ncbi.nlm.nih.gov/pubmed/22714537,22714537,,
163,1455535,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10084,PQBP1,https://ctdbase.org/detail.go?type=gene&acc=10084,,,10084,PQBP1,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PQBP1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
164,1455536,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,188802,PQN-71,https://ctdbase.org/detail.go?type=gene&acc=188802,,,188802,pqn-71,6239,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of PQN-71 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
165,1455537,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,178294,PQN-74,https://ctdbase.org/detail.go?type=gene&acc=178294,,,178294,pqn-74,6239,Caenorhabditis elegans,[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of PQN-74 mRNA,,,PMID:23534459,https://www.ncbi.nlm.nih.gov/pubmed/23534459,23534459,,
166,1455792,444031,DrugBank,Darifenacin,DB00496,Darifenacin,https://www.drugbank.ca/drugs/DB00496,BE0002363,Cytochrome P450 2D6,https://www.drugbank.ca/bio_entities/BE0002363,P10635,Cytochrome P450 2D6,1565,CYP2D6,9606,Homo sapiens (human),Substrate|Inhibitor,,,PMID:16584282,https://www.ncbi.nlm.nih.gov/pubmed/16584282,16584282,,
167,1493227,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2788,GNG7,https://ctdbase.org/detail.go?type=gene&acc=2788,,,2788,GNG7,9606,Homo sapiens (human),Trichostatin A affects the expression of GNG7 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
168,1493228,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2792,GNGT1,https://ctdbase.org/detail.go?type=gene&acc=2792,,,2792,GNGT1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNGT1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
169,1493729,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8204,NRIP1,https://ctdbase.org/detail.go?type=gene&acc=8204,,,8204,NRIP1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRIP1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
170,1493730,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8204,NRIP1,https://ctdbase.org/detail.go?type=gene&acc=8204,,,8204,NRIP1,9606,Homo sapiens (human),Trichostatin A affects the expression of NRIP1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
171,1494109,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,368223,GPM6AA,https://ctdbase.org/detail.go?type=gene&acc=368223,,,368223,gpm6aa,7955,Danio rerio (zebrafish),Trichostatin A results in decreased expression of GPM6AA mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
172,1494110,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2824,GPM6B,https://ctdbase.org/detail.go?type=gene&acc=2824,,,2824,GPM6B,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPM6B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
173,1494111,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2824,GPM6B,https://ctdbase.org/detail.go?type=gene&acc=2824,,,2824,GPM6B,9606,Homo sapiens (human),Trichostatin A results in increased expression of GPM6B mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
174,1494112,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2824,GPM6B,https://ctdbase.org/detail.go?type=gene&acc=2824,,,2824,GPM6B,8355,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of GPM6B mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
175,1494113,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10457,GPNMB,https://ctdbase.org/detail.go?type=gene&acc=10457,,,10457,GPNMB,9606,Homo sapiens (human),Trichostatin A results in increased expression of GPNMB mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
176,1494114,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,56834,GPR137,https://ctdbase.org/detail.go?type=gene&acc=56834,,,56834,GPR137,7955,Danio rerio (zebrafish),Trichostatin A results in increased expression of GPR137 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
177,1494115,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7107,GPR137B,https://ctdbase.org/detail.go?type=gene&acc=7107,,,7107,GPR137B,9606,Homo sapiens (human),Trichostatin A results in increased expression of GPR137B mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
178,1494116,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,283554,GPR137C,https://ctdbase.org/detail.go?type=gene&acc=283554,,,283554,GPR137C,9606,Homo sapiens (human),Trichostatin A results in increased expression of GPR137C mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
179,1493564,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1289,COL5A1,https://ctdbase.org/detail.go?type=gene&acc=1289,,,1289,COL5A1,9606,Homo sapiens (human),Tretinoin results in decreased expression of COL5A1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
180,1493565,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1289,COL5A1,https://ctdbase.org/detail.go?type=gene&acc=1289,,,1289,COL5A1,10090,Mus musculus (house mouse),[bisphenol A co-treated with tretinoin] results in decreased expression of COL5A1 mrna|[bisphenol F co-treated with tretinoin] results in decreased expression of COL5A1 mrna|[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of COL5A1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
181,1493566,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1289,COL5A1,https://ctdbase.org/detail.go?type=gene&acc=1289,,,1289,COL5A1,10090,Mus musculus (house mouse),Tretinoin results in increased expression of COL5A1 mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
182,1493567,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1290,COL5A2,https://ctdbase.org/detail.go?type=gene&acc=1290,,,1290,COL5A2,9606,Homo sapiens (human),Tretinoin results in increased expression of COL5A2 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
183,1493568,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1290,COL5A2,https://ctdbase.org/detail.go?type=gene&acc=1290,,,1290,COL5A2,10090,Mus musculus (house mouse),[bisphenol F co-treated with tretinoin] results in decreased expression of COL5A2 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
184,1495088,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,65250,CPLANE1,https://ctdbase.org/detail.go?type=gene&acc=65250,,,65250,CPLANE1,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPLANE1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
185,1495089,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10815,CPLX1,https://ctdbase.org/detail.go?type=gene&acc=10815,,,10815,CPLX1,10090,Mus musculus (house mouse),Tretinoin results in decreased expression of CPLX1 mRNA,,,PMID:37278767,https://www.ncbi.nlm.nih.gov/pubmed/37278767,37278767,,
186,1495090,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,594855,CPLX3,https://ctdbase.org/detail.go?type=gene&acc=594855,,,594855,CPLX3,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPLX3 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
187,1495091,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1368,CPM,https://ctdbase.org/detail.go?type=gene&acc=1368,,,1368,CPM,9606,Homo sapiens (human),Tretinoin results in increased expression of CPM mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
188,1495092,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,221184,CPNE2,https://ctdbase.org/detail.go?type=gene&acc=221184,,,221184,CPNE2,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPNE2 mRNA,,,PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|33167477,,
189,1495093,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,131034,CPNE4,https://ctdbase.org/detail.go?type=gene&acc=131034,,,131034,CPNE4,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPNE4 mRNA,,,PMID:21934132|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/23724009,21934132|23724009,,
190,1495094,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55313,CPPED1,https://ctdbase.org/detail.go?type=gene&acc=55313,,,55313,CPPED1,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPPED1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
191,1494791,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,63976,PRDM16,https://ctdbase.org/detail.go?type=gene&acc=63976,,,63976,PRDM16,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PRDM16 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
192,1494792,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,63976,PRDM16,https://ctdbase.org/detail.go?type=gene&acc=63976,,,63976,PRDM16,10090,Mus musculus (house mouse),[dietary fats co-treated with resveratrol] results in increased expression of PRDM16 mRNA,,,PMID:29197120,https://www.ncbi.nlm.nih.gov/pubmed/29197120,29197120,,
193,1494793,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,63976,PRDM16,https://ctdbase.org/detail.go?type=gene&acc=63976,,,63976,PRDM16,10090,Mus musculus (house mouse),PRKAA1 gene mutant form inhibits the reaction [resveratrol results in increased expression of PRDM16 mrna]|resveratrol results in increased expression of PRDM16 protein|dorsomorphin inhibits the reaction [resveratrol results in increased expression of PRDM16 protein]|resveratrol results in increased expression of PRDM16 mrna|prkaa1 gene mutant form inhibits the reaction [resveratrol results in increased expression of PRDM16 protein],,,PMID:25761413,https://www.ncbi.nlm.nih.gov/pubmed/25761413,25761413,,
194,1494794,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,440556,PRDM16-DT,https://ctdbase.org/detail.go?type=gene&acc=440556,,,440556,PRDM16-DT,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PRDM16-DT mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
195,1493895,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,9475,ROCK2,https://ctdbase.org/detail.go?type=gene&acc=9475,,,9475,ROCK2,10116,Rattus norvegicus (Norway rat),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of ROCK2 protein,,,PMID:10998351,https://www.ncbi.nlm.nih.gov/pubmed/10998351,10998351,,
196,1493896,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,6197,RPS6KA3,https://ctdbase.org/detail.go?type=gene&acc=6197,,,6197,RPS6KA3,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased activity of RPS6KA3 protein,,,PMID:10998351,https://www.ncbi.nlm.nih.gov/pubmed/10998351,10998351,,
197,1494795,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,3759,KCNJ2,https://ctdbase.org/detail.go?type=gene&acc=3759,,,3759,KCNJ2,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [TGFB1 protein results in decreased expression of KCNJ2 protein],,,PMID:22853924,https://www.ncbi.nlm.nih.gov/pubmed/22853924,22853924,,
198,1494796,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,3784,KCNQ1,https://ctdbase.org/detail.go?type=gene&acc=3784,,,3784,KCNQ1,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [isoproterenol results in increased activity of [KCNQ1 protein binds to KCNE1 protein]],,,PMID:16909339,https://www.ncbi.nlm.nih.gov/pubmed/16909339,16909339,,
199,1494797,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,3827,KNG1,https://ctdbase.org/detail.go?type=gene&acc=3827,,,3827,KNG1,10116,Rattus norvegicus (Norway rat),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [KNG1 promotes the reaction [capsaicin results in increased secretion of TAC1 protein]],,,PMID:15750287,https://www.ncbi.nlm.nih.gov/pubmed/15750287,15750287,,
200,1494798,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952,LEP,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide results in decreased susceptibility to LEP protein|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LEP protein results in increased expression of CCL2]|N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LEP protein results in increased chemical synthesis of reactive oxygen species],,,PMID:11342529,https://www.ncbi.nlm.nih.gov/pubmed/11342529,11342529,,
201,1494799,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952,LEP,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LEP protein results in increased expression of CYP19A1 protein],,,PMID:28571770,https://www.ncbi.nlm.nih.gov/pubmed/28571770,28571770,,
202,1494800,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952,LEP,10090,Mus musculus (house mouse),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [simvastatin results in decreased expression of LEP mrna],,,PMID:19254925,https://www.ncbi.nlm.nih.gov/pubmed/19254925,19254925,,
203,1494801,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,29124,LGALS13,https://ctdbase.org/detail.go?type=gene&acc=29124,,,29124,LGALS13,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [colforsin results in increased expression of LGALS13 mrna],,,PMID:35908931,https://www.ncbi.nlm.nih.gov/pubmed/35908931,35908931,,
204,1494961,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972,LHB,10090,Mus musculus (house mouse),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LHB protein results in increased abundance of HAS2 mrna]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LHB protein results in increased abundance of PTGS2 mrna]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LHB protein results in increased abundance of CEBPB mrna]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LHB protein results in increased abundance of TNFAIP6 mrna]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [LHB protein results in increased abundance of PGR mrna],,,PMID:21220312,https://www.ncbi.nlm.nih.gov/pubmed/21220312,21220312,,
205,1494962,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,3991,LIPE,https://ctdbase.org/detail.go?type=gene&acc=3991,,,3991,LIPE,10090,Mus musculus (house mouse),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide affects the reaction [bucladesine results in increased expression of and results in increased phosphorylation of LIPE protein]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [bucladesine results in increased expression of LIPE mrna],,,PMID:23362264,https://www.ncbi.nlm.nih.gov/pubmed/23362264,23362264,,
206,1494963,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,3991,LIPE,https://ctdbase.org/detail.go?type=gene&acc=3991,,,3991,LIPE,10090,Mus musculus (house mouse),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[licarin A affects the susceptibility to [INS protein co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone]] which results in increased expression of LIPE protein modified form]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[licarin A affects the susceptibility to [INS protein co-treated with 1-methyl-3-isobutylxanthine co-treated with dexamethasone]] which results in increased expression of LIPE protein],,,PMID:29288687,https://www.ncbi.nlm.nih.gov/pubmed/29288687,29288687,,
207,1494964,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,3991,LIPE,https://ctdbase.org/detail.go?type=gene&acc=3991,,,3991,LIPE,10090,Mus musculus (house mouse),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [thioctic acid results in increased phosphorylation of LIPE protein],,,PMID:22941773,https://www.ncbi.nlm.nih.gov/pubmed/22941773,22941773,,
208,1494965,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594,MAPK1,307972,Apostichopus japonicus (Japanese sea cucumber),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[estradiol results in increased activity of GPER1 protein] which results in increased phosphorylation of MAPK1 protein]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[GPER1 protein co-treated with estradiol] results in increased phosphorylation of MAPK1 protein],,,PMID:37372083,https://www.ncbi.nlm.nih.gov/pubmed/37372083,37372083,,
209,1494966,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594,MAPK1,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased phosphorylation of MAPK1 protein],,,PMID:16671086,https://www.ncbi.nlm.nih.gov/pubmed/16671086,16671086,,
210,1494967,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594,MAPK1,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [selegiline results in increased phosphorylation of MAPK1 protein],,,PMID:16099847,https://www.ncbi.nlm.nih.gov/pubmed/16099847,16099847,,
